Groundbreaking phase 3 Alzheimer’s clinical trial at UW in need of volunteers
The University of Wisconsin School of Medicine and Public Health is recruiting volunteers for a study testing an investigational treatment that aims to help prevent the earliest memory loss due to Alzheimer’s disease.
UW begins new clinical trial to treat fatal blood diseases in children, young adults
A clinical trial has launched at the UW School of Medicine and Public Health to test the safety of a new type of stem cell transplantation to treat a variety of deadly blood disorders in children and young adults.
Patient with rare cancer uses telehealth to access clinical trial
Today is National Clinical Trials Day, and UW Health wants to celebrate the researchers, nurses, physicians and experts in the lab who make clinical trials available and impactful for our patients and community. UW Health officials also say virtual consultations have been vital to expanding access to clinical trials for Wisconsin residents, especially during the pandemic.
New UW study examines immune response to COVID-19 vaccine in patients with inflammatory bowel disease
A new study at the University of Wisconsin School of Medicine and Public Health is looking at the immune response to COVID-19 vaccines in patients with inflammatory bowel disease (IBD). Enrollment is open now for patients who fit the criteria.
UW COVID-19 prevention study expands enrollment to essential workers
All essential workers who cannot perform work duties remotely are now eligible to take part in a prevention research study at the University of Wisconsin School of Medicine and Public Health. The study is investigating whether commonly used oral and nasal antiseptic, in addition to masks and hand hygiene, can help prevent COVID-19 infections. These workers include police officers, firefighters, daycare workers, grocery store workers, retail employees, restaurant staff, mail carriers and bus drivers, etc.
All of Us Research Program returns first genetic results to participants
Participants who donated biosamples, as part of the historic “All of Us” Research Program, may soon see a return of their genetic results.
First-in-humans clinical trial to treat children with relapsed neuroblastoma opens at American Family Children’s Hospital
A first-in-humans clinical trial for children with relapsed or refractory neuroblastoma has opened at American Family Children’s Hospital (AFCH) and is being conducted by researchers at University of Wisconsin School of Medicine and Public Health. Neuroblastoma is one of the most common solid tumors in children. Patients who are classified as “high-risk” (about 40 percent of those diagnosed) have less than a 50 percent survival rate.
UW set to resume enrollment for AstraZeneca’s investigational COVID-19 vaccine
A clinical trial of an investigational COVID-19 vaccine has resumed in the United States after the FDA and an independent safety review board completed their review of a trial participant in the United Kingdom who became ill.
AstraZeneca COVID-19 vaccine clinical trial resumes at UW
AstraZeneca announced that the COVID-19 vaccine trial has resumed in the United States, including at UW Health and the UW School of Medicine and Public Health, after the FDA and an independent safety review board completed their review of an illness contracted by a trial participant in the United Kingdom.
UW Health and UW School of Medicine and Public Health launch new Study Finder
UW Health and the UW School of Medicine and Public Health have launched the UW Health Study Finder, a new, easily accessible website that lists UW studies and clinical trials that are currently recruiting participants.
UW Carbone Cancer Center receives FDA clearance to test new regenerative medicine therapy for radiotherapy-induced dry mouth
The University of Wisconsin Carbone Cancer Center has the go-ahead to start clinical trials on a first-in-human cell therapy to treat a common side effect of radiation therapy.
UW Health and University of Wisconsin selected as one of first clinical sites in the U.S. to test new COVID-19 vaccine
UW Health and the University of Wisconsin School of Medicine and Public Health (SMPH) are among the first sites in the country to study whether an investigational vaccine developed by the pharmaceutical company AstraZeneca can prevent COVID-19, the disease caused by the new coronavirus SARS-CoV-2.